IIL has been exporting Animal Health vaccines and formulations & Human Health vaccines, across the world for more than fifteen years.
IIL’s global footprint started by supplying Foot and Mouth Disease (FMD) vaccine to United Nations Food and Agriculture Organization (UNFAO) to support their animal health rehabilitation program across the developing countries.
International Business Division (IBD) operates both Animal and Human health under one arm:
ANIMAL HEALTH DIVISION:
Today, IIL supplies Animal Health vaccines to more than 45 countries in the world with a customer focus in Middle East, Asia Pacific Region, Africa, Russia & CIS countries.
IIL’s presence in the global animal health market is more than a decade old and its reach extends to all the continents across the world with more than 150 product registrations. IIL has a sizable presence in FMD and Rabies vaccine market. IIL’s adherence to highest standards of quality and to its commitments has helped it carve out a name for itself. The consistent approach to business and being a stickler to the highest of standards has ensured in it being considered as as one of the top 10 animal health company in the world for its Service, Research, Innovation, Quality, Cold chain systems and presence in International forums.
In Asia, IIL is the leading veterinary biological company, manufacturing vaccines with a range of products targeted for Cattle, Sheep, Goat and Canine segment, having unique vaccine customization capability to meet the requirements of importing countries. IIL’s commitment in quality manufacturing has brought the biggest applaud to its credit by having the co-marketing tie up with the world’s No.1 pharmaceutical company for the South East Asian markets.
IIL established a new state of the art Animal Health Formulations (AHF) manufacturing facility for tablets, boli and injectable at different volume and sizes. The facility will meet cGMP compliance in line with USDA, EMEA and WHO requirements. We support new customized requirements of the partners by either offering contract manufacturing or product development, licensing and manufacturing models.
HUMAN HEALTH DIVISION:
IIL made inroads in global human vaccine market with the launch of Abhayrab – India’s first and world’s second PVRV rabies vaccine. IIL’s human health vaccines are registered in more than 20 countries and are used in National Immunization programs.
IIL’s presence in the global human health segment for UIP range of vaccines paved way to bid for the UNICEF tender to supply all developing nations and works towards filing the PSF for obtaining WHO Pre-Qualification in the coming years. The human rabies vaccine – Abhayrab is the brand leader in few of the Asian countries and used regularly in all the importing countries national rabies
IIL’s manufacturing facility has got the track record of complying and surpassing the International audits conducted by the importing countries in line with their National Regulation for registration of products.